AU7277987A - Pharmaceutically active tetrahydronaphthalene derivatives - Google Patents

Pharmaceutically active tetrahydronaphthalene derivatives

Info

Publication number
AU7277987A
AU7277987A AU72779/87A AU7277987A AU7277987A AU 7277987 A AU7277987 A AU 7277987A AU 72779/87 A AU72779/87 A AU 72779/87A AU 7277987 A AU7277987 A AU 7277987A AU 7277987 A AU7277987 A AU 7277987A
Authority
AU
Australia
Prior art keywords
pharmaceutically active
tetrahydronaphthalene derivatives
active tetrahydronaphthalene
derivatives
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72779/87A
Other languages
English (en)
Inventor
Michael Klaus
Peter Loeliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1938/86A external-priority patent/CH668962A5/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU7277987A publication Critical patent/AU7277987A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
AU72779/87A 1986-05-13 1987-05-12 Pharmaceutically active tetrahydronaphthalene derivatives Abandoned AU7277987A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1938/86A CH668962A5 (de) 1986-05-13 1986-05-13 Tetrahydronaphthyl-propenyl-phenole.
CH1938/86 1986-05-13
CH742/87 1987-02-26
CH74287 1987-02-26

Publications (1)

Publication Number Publication Date
AU7277987A true AU7277987A (en) 1987-11-19

Family

ID=25685550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72779/87A Abandoned AU7277987A (en) 1986-05-13 1987-05-12 Pharmaceutically active tetrahydronaphthalene derivatives

Country Status (20)

Country Link
CN (1) CN87103524A (sv)
AU (1) AU7277987A (sv)
BE (1) BE1001668A5 (sv)
DE (1) DE3715809A1 (sv)
DK (1) DK232087A (sv)
ES (1) ES2005572A6 (sv)
FI (1) FI872027A (sv)
FR (1) FR2598706B1 (sv)
GB (1) GB2190378B (sv)
HU (1) HU198002B (sv)
IL (1) IL82448A0 (sv)
IT (1) IT1203954B (sv)
LU (1) LU86866A1 (sv)
MC (1) MC1817A1 (sv)
NL (1) NL8701101A (sv)
NO (1) NO871961L (sv)
NZ (1) NZ220215A (sv)
PT (1) PT84860B (sv)
SE (1) SE8701933L (sv)
ZW (1) ZW6587A1 (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
CA2017956A1 (en) * 1989-07-06 1991-01-06 Werner Bollag Use of retinoids
US5183827A (en) * 1989-09-19 1993-02-02 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5264456A (en) * 1989-12-29 1993-11-23 Allergan, Inc. Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5475022A (en) * 1993-10-18 1995-12-12 Allergan, Inc. Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
US5426118A (en) * 1993-12-30 1995-06-20 Allergan, Inc. [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5618931A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5618943A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5543534A (en) * 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5556996A (en) * 1994-12-29 1996-09-17 Allergan Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5534641A (en) 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US6025388A (en) 1995-04-26 2000-02-15 Allergan Sales, Inc. Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
US5616712A (en) * 1995-05-16 1997-04-01 Allergan Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
US5675033A (en) * 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5965606A (en) 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US5688957A (en) * 1995-12-29 1997-11-18 Allergan (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5741896A (en) * 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) * 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5747542A (en) * 1996-06-21 1998-05-05 Allergan Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
CA1162200A (en) * 1981-02-13 1984-02-14 Michael Klaus Process for the manufacture of indanyl (or tetrahydronaphthyl)propenyl phenyl derivatives
EP0084667B1 (de) * 1982-01-23 1985-09-18 BASF Aktiengesellschaft Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
GB8711205D0 (en) 1987-06-17
IT1203954B (it) 1989-02-23
FI872027A0 (fi) 1987-05-07
FI872027A (fi) 1987-11-14
SE8701933D0 (sv) 1987-05-11
IL82448A0 (en) 1987-11-30
ZW6587A1 (en) 1987-12-02
FR2598706A1 (fr) 1987-11-20
IT8720232A0 (it) 1987-04-23
NZ220215A (en) 1990-06-26
HUT43806A (en) 1987-12-28
GB2190378B (en) 1990-11-14
HU198002B (en) 1989-07-28
SE8701933L (sv) 1987-11-14
PT84860B (pt) 1990-02-08
GB2190378A (en) 1987-11-18
LU86866A1 (de) 1988-06-13
MC1817A1 (fr) 1988-03-18
FR2598706B1 (fr) 1990-07-06
NO871961D0 (no) 1987-05-12
NO871961L (no) 1987-11-16
DK232087D0 (da) 1987-05-06
DK232087A (da) 1987-11-14
CN87103524A (zh) 1987-12-02
BE1001668A5 (fr) 1990-02-06
NL8701101A (nl) 1987-12-01
ES2005572A6 (es) 1989-03-16
PT84860A (en) 1987-06-01
DE3715809A1 (de) 1987-11-19

Similar Documents

Publication Publication Date Title
AU7277987A (en) Pharmaceutically active tetrahydronaphthalene derivatives
AU6062590A (en) Pharmaceutically active compounds
AU1709888A (en) Pharmaceutically active amines
KR960004771B1 (en) Pharmacologically active catechol derivatives
AU591564B2 (en) 5-acylamino-pyrazole derivatives
AU7360887A (en) Pharmacologically active 1,5-diarly-3-substituted- pyrazoles and method for synthesizing the same
AU7299387A (en) Imidazoquinolinylether derivatives
PT86000A (en) Pharmaceutically active compounds
AU1032992A (en) Pharmacologically active substituted oxybenzamides
AU575745B2 (en) Alkylsulfonanilide derivatives
AU5300386A (en) Pharmaceutically active podophyllotoxins
AU590687B2 (en) 5-acylamino-pyrazole derivatives
AU573115B2 (en) 2b-substituted thiomethylpenicillin derivatives
AU6581186A (en) Pharmaceutically active hererocyclic compounds
AU7045587A (en) 5-amino-1-aryl-pyrazole derivatives
AU6989587A (en) Arylazolylmethylbenzocycloalkene derivatives
AU6886087A (en) 2-cyanobenimidazole derivatives
AU581809B2 (en) Indenopyrimidine derivatives
AU5140390A (en) Tetrahydronaphthalene derivatives
GB8622090D0 (en) Pharmacologically active compounds
AU7219287A (en) Benzoxazolyl- and benzthiazolyl-aniline derivatives
AU7226487A (en) Alkenamide derivatives
EP0366614A3 (en) Pharmaceutically active dithioketene derivatives
GB8921069D0 (en) Pharmaceutically active compound,preparation and use
AU7534787A (en) Pharmacologically active compounds and use